| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MAX interactor 1, dimerization protein | 0.547 | 0.615 | 1.1E-03 |
|
disease | 0.660 | None | 1.000 | 0 | 0 | 1995 | 2001 | ||||||||
|
Kruppel like factor 6 | 0.501 | 0.846 | 0.98 |
|
disease | 0.500 | None | 0.857 | 0 | 0 | 2001 | 2018 | ||||||||
|
mitotic arrest deficient 1 like 1 | 0.570 | 0.731 | 6.8E-16 |
|
disease | 0.400 | None | 0 | 0 | |||||||||||
|
BRCA2 DNA repair associated | 0.379 | 0.846 | 2.4E-25 |
|
disease | 0.900 | strong | 0.948 | 1 | 0 | 1996 | 2020 | ||||||||
|
checkpoint kinase 2 | 0.460 | 0.808 | 1.2E-24 |
|
disease | 0.800 | None | 0.963 | 1 | 0 | 2003 | 2019 | ||||||||
|
transforming growth factor beta receptor 2 | 0.413 | 0.846 | 0.13 |
|
disease | 0.600 | None | 1.000 | 1 | 0 | 2006 | 2018 | ||||||||
|
fibroblast growth factor receptor 4 | 0.490 | 0.769 | 7.2E-13 |
|
disease | 0.600 | None | 0.929 | 1 | 0 | 2004 | 2016 | ||||||||
|
cyclin D1 | 0.344 | 0.923 | 0.89 |
|
disease | 0.600 | None | 0.952 | 1 | 0 | 1998 | 2020 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
disease | 0.600 | None | 1.000 | 1 | 0 | 2005 | 2018 | ||||||||
|
BRCA1 DNA repair associated | 0.367 | 0.923 | 9.2E-29 |
|
disease | 0.500 | None | 0.928 | 1 | 0 | 1995 | 2020 | ||||||||
|
prostate cancer associated transcript 1 | 0.575 | 0.615 |
|
disease | 0.500 | None | 1.000 | 1 | 0 | 2005 | 2019 | |||||||||
|
solute carrier family 22 member 3 | 0.531 | 0.846 | 7.8E-10 |
|
disease | 0.470 | None | 1.000 | 1 | 0 | 2007 | 2020 | ||||||||
|
regulatory factor X6 | 0.686 | 0.385 | 4.1E-04 |
|
disease | 0.460 | None | 1.000 | 1 | 0 | 2010 | 2016 | ||||||||
|
C-terminal binding protein 2 | 0.638 | 0.615 | 1.4E-03 |
|
disease | 0.460 | None | 1.000 | 1 | 0 | 2008 | 2018 | ||||||||
|
lipid droplet associated hydrolase | 0.839 | 0.231 | 3.6E-04 |
|
disease | 0.450 | None | 1.000 | 1 | 0 | 2010 | 2018 | ||||||||
|
forkhead box P4 | 0.700 | 0.346 | 0.98 |
|
disease | 0.440 | None | 1.000 | 1 | 0 | 2010 | 2019 | ||||||||
|
lemur tyrosine kinase 2 | 0.729 | 0.462 | 1.00 |
|
disease | 0.440 | None | 1.000 | 1 | 0 | 2008 | 2016 | ||||||||
|
partner and localizer of BRCA2 | 0.485 | 0.769 | 3.0E-19 |
|
disease | 0.430 | None | 1.000 | 1 | 0 | 2018 | 2019 | ||||||||
|
EH domain binding protein 1 | 0.839 | 0.231 | 0.31 |
|
disease | 0.420 | None | 1.000 | 1 | 0 | 2008 | 2016 | ||||||||
|
fibroblast growth factor 10 | 0.530 | 0.692 | 0.94 |
|
disease | 0.410 | None | 1.000 | 1 | 0 | 2011 | 2019 | ||||||||
|
DNA polymerase kappa | 0.691 | 0.423 | 7.5E-13 |
|
disease | 0.410 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
cytochrome P450 family 3 subfamily A member 4 | 0.462 | 0.885 | 5.8E-11 |
|
disease | 0.400 | None | 0.844 | 1 | 0 | 1998 | 2017 | ||||||||
|
caspase 9 | 0.458 | 0.808 | 7.4E-06 |
|
disease | 0.400 | None | 0.909 | 1 | 0 | 2001 | 2017 | ||||||||
|
suppression of tumorigenicity 14 | 0.514 | 0.769 | 0.56 |
|
disease | 0.400 | None | 1.000 | 1 | 0 | 2007 | 2019 | ||||||||
|
angiotensin I converting enzyme | 0.328 | 0.923 | 1.0E-37 |
|
disease | 0.400 | None | 0.833 | 1 | 0 | 2004 | 2019 |